Tag: Percutaneous Deep Vein Arterialisation
Positive two-year data from ALPS registry of LimFlow system published
LimFlow SA today announced publication of positive two-year data from the ALPS registry of the LimFlow percutaneous deep vein arterialisation (pDVA) system. Results were...
Positive two-year data from ALPS registry of LimFlow system published
LimFlow SA today announced publication of positive two-year data from the ALPS registry of the LimFlow percutaneous deep vein arterialisation (pDVA) system. Results were...
VIVA 2019: PROMISE I trial shows deep vein arterialisation offers hope...
Daniel Clair (Columbia, SC, USA), presented positive six-month data from the full patient cohort of the PROMISE I early feasibility study of the LimFlow...
US FDA grants IDE approval to LimFlow for Percutaneous Deep Vein...
The US Food and Drug Administration (FDA) has approved LimFlow’s Investigational Device Exemption for a feasibility study of the company’s Percutaneous Deep Vein Arterialisation...
